Move-It 動起來: A cluster-randomised digital worksite exercise intervention in China: outcome and process evaluation
H Blake, B Lai, J Houdmont, A Griffiths - Trials - nottingham-repository.worktribe.com
… is an open-label, multi-centre phase IIa platform trial, … of two-phase II trials but will be refined
with results from on… Data collection for the study is electronic with patient reported outcomes, …
with results from on… Data collection for the study is electronic with patient reported outcomes, …
磁共振引导经颅超声聚焦治疗特发性震颤: 一项前瞻性, 单中心, 单臂研究
R Zong, X Li, C Yin, J He, D Zhang, X Bian… - 中国神经再生研究 …, 2024 - sjzsyj.com.cn
… center, open-label, single-arm study was part of a worldwide prospective multicenter
clinical trial (… The treatment was concluded if we observed tremor improvement, patient-reported …
clinical trial (… The treatment was concluded if we observed tremor improvement, patient-reported …
[HTML][HTML] 口服S-1 方案治疗转移性结直肠癌疗效与安全性的Meta 分析
赵娟娟， 雷鑫明 - 世界华人消化杂志, 2019 - wjgnet.com
… Controlled trials evaluating S-1-based regimens for the treatment of mCRC from January …
metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009;10:1063-1069. …
metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009;10:1063-1069. …
[HTML][HTML] 非小细胞肺癌免疫治疗生物标志物的研究进展
黄川， 杨雪 - Chinese Journal of Lung Cancer, 2021 - ncbi.nlm.nih.gov
… 这是一项国际化、随机、III期临床研究，评估了帕博利珠单抗对比铂类为基础的化疗用于未经治疗
PD-L1肿瘤比例评分（tumor proportional score, TPS）≥50%且无EGFR突变或ALK易位的晚期…
PD-L1肿瘤比例评分（tumor proportional score, TPS）≥50%且无EGFR突变或ALK易位的晚期…
[PDF][PDF] 紫杉醇联合奈达铂新辅助治疗局部晚期宫颈癌的临床效果研究
郑霞， 魏莉， 朱烨， 邵娟， 王博 - 现代生物医学进展, 2018 - biomed.cnjournals.com
… papillomavirus: end of study results from the ATHENA study … : patient-reported outcomes
of a randomised, phase 3 trial (… : The Open-Label Randomized Phase III Trial JCOG0505 [J]. …
of a randomised, phase 3 trial (… : The Open-Label Randomized Phase III Trial JCOG0505 [J]. …
[HTML][HTML] 中国非小细胞肺癌免疫检查点抑制剂治疗专家共识（ 2020 年版）
周彩存， 王洁， 王宝成， 程颖， 王哲海… - Chinese Journal of …, 2021 - ncbi.nlm.nih.gov
… Summary of results from phase Ⅲ clinical trials of ICIs as first-line therapy for advanced …
Summary of results from phase Ⅲ clinical trials of ICIs as second-line therapy for advanced …
Summary of results from phase Ⅲ clinical trials of ICIs as second-line therapy for advanced …